Angioedema attacks in patients with hereditary angioedema: Local manifestations of a systemic activation process (original) (raw)
2016, Journal of Allergy and Clinical Immunology
receives research support from University Medical Center Utrecht. A. Relan is an employee of and stockholder in Pharming Technologies. S. Zeerleder receives research support from Viropharma. C. Drouet receives research support from GREPI and travel support from UCSD and the National Institutes of health. B. Zuraw serves as a consultant for Allan, Arrowhead, BioCryst, CSL Behring, Dyax, Ionis, Nektar, Shire and Salix; receives clinical research support from Ionis and received travel assistances from US HAEA. C. E. Hack is the founder of and a stockholder in Prothix BV.
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.